跳至主要内容
临床试验/NCT05714098
NCT05714098已完成不适用

Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)

Duke University2 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2023年3月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
33
试验地点
2
主要终点
Feasibility, as measured by number of participants completing at least 50% of the exercise sessions

研究概览

简要总结

The purpose of this study to assess the feasibility, acceptability, and safety of a personalized exercise training program adapted from Gerofit to improve physical health and quality of life for adults with SCD

详细描述

The purpose of this study is to adapt and pilot the Gerofit personalized exercise intervention for older adults with sickle cell disease (age ≥ 40 years). The Sickle Cell Disease Functional Assessment (SCD-FA) will be performed at steady state at baseline and every 3 months to track progress. Endpoints include feasibility, acceptability, and safety. All participants will be interviewed to identify barriers and facilitators to exercise and how to better optimize the exercise intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a diagnosis of sickle cell disease (any genotype) confirmed by hemoglobin electrophoresis, high performance liquid chromatography, or genotyping
  • Understand and speak fluent English.

排除标准

  • Diagnosed with moderate or severe cognitive impairment based on ICD-10 codes or report from their outpatient provider
  • Unable to self-consent
  • Wheelchair-bound
  • Successfully treated with hematopoietic stem cell transplantation for SCD
  • Have moderate to severe uncorrected visual or auditory impairment
  • Oxygen-dependent
  • Have severe avascular necrosis requiring an assist device
  • Unstable cardiac disease.

研究组 & 干预措施

Exercise

Experimental

Each cohort of 5-8 participants will exercise 3 days a week for up to 12 weeks. Exercise sessions will be virtual

干预措施: Gerofit Exercise Program (Behavioral)

结局指标

主要结局

Feasibility, as measured by number of participants completing at least 50% of the exercise sessions

时间窗: 12 weeks

Feasibility, as Measured by Number of Participants Completing at Least 50% of the Exercise Sessions

时间窗: 12 weeks

次要结局

  • Safety, as measured by number of participants with moderate or severe adverse events(12 weeks)
  • Acceptability, as measured by acceptability survey(12 weeks)
  • Safety, as Measured by Number of Participants With Moderate or Severe Adverse Events(12 weeks)
  • Acceptability, as Measured by the Number of Participants Reporting the Intervention as Acceptable(12 weeks)

研究者

发起方
Duke University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验